NO20015378D0 - Cyclocarbamate derivatives as progesterone receptor modulators - Google Patents

Cyclocarbamate derivatives as progesterone receptor modulators

Info

Publication number
NO20015378D0
NO20015378D0 NO20015378A NO20015378A NO20015378D0 NO 20015378 D0 NO20015378 D0 NO 20015378D0 NO 20015378 A NO20015378 A NO 20015378A NO 20015378 A NO20015378 A NO 20015378A NO 20015378 D0 NO20015378 D0 NO 20015378D0
Authority
NO
Norway
Prior art keywords
receptor modulators
progesterone receptor
cyclocarbamate
derivatives
cyclocarbamate derivatives
Prior art date
Application number
NO20015378A
Other languages
Norwegian (no)
Other versions
NO321361B1 (en
NO20015378L (en
Inventor
Puwen Zhang
Eugene A Terefenko
III Horace FLETCHER
Andrew Fensome
Jay E Wrobel
Lin Zhi
Todd K Jones
Christopher M Tegley
James P Edwards
Original Assignee
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by Ligand Pharm Inc filed Critical Ligand Pharm Inc
Publication of NO20015378D0 publication Critical patent/NO20015378D0/en
Publication of NO20015378L publication Critical patent/NO20015378L/en
Publication of NO321361B1 publication Critical patent/NO321361B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
NO20015378A 1999-05-04 2001-11-02 Cyclo-carbamate derivatives, their use as a medicament, a pharmaceutical preparation, and the use of the derivatives for the manufacture of medicaments. NO321361B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011822 WO2000066571A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (3)

Publication Number Publication Date
NO20015378D0 true NO20015378D0 (en) 2001-11-02
NO20015378L NO20015378L (en) 2002-01-03
NO321361B1 NO321361B1 (en) 2006-05-02

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015378A NO321361B1 (en) 1999-05-04 2001-11-02 Cyclo-carbamate derivatives, their use as a medicament, a pharmaceutical preparation, and the use of the derivatives for the manufacture of medicaments.

Country Status (19)

Country Link
EP (1) EP1173426A1 (en)
JP (1) JP2002543193A (en)
KR (1) KR20010114250A (en)
CN (1) CN1145618C (en)
AU (1) AU766428B2 (en)
BG (1) BG106079A (en)
BR (1) BR0010213A (en)
CA (1) CA2371726A1 (en)
CZ (1) CZ20013951A3 (en)
EA (1) EA004512B1 (en)
HU (1) HUP0201609A3 (en)
IL (1) IL146280A0 (en)
MX (1) MXPA01011286A (en)
NO (1) NO321361B1 (en)
NZ (1) NZ515355A (en)
PL (1) PL351127A1 (en)
SG (1) SG114650A1 (en)
SK (1) SK15912001A3 (en)
TR (1) TR200103286T2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1946716B (en) * 2004-04-27 2011-12-21 惠氏公司 Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
WO2006077821A1 (en) * 2005-01-19 2006-07-27 Dainippon Sumitomo Pharma Co., Ltd. Aromatic sulfone compound as aldosterone receptor modulator
AU2008308092B2 (en) 2007-10-05 2013-07-11 Msd K.K. Benzoxazinone derivative
CN111925353B (en) * 2020-08-31 2022-04-08 苏州大学附属第二医院 Preparation method of 2-thiophenecarbonitrile

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
JPH10510840A (en) * 1994-12-22 1998-10-20 リガンド・ファーマシューティカルズ・インコーポレイテッド Steroid receptor modulator compounds and methods
DE69724630T2 (en) * 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-DISUBSTITUTED 1,4-DIHYDRO-2H-3,1-BENZOXAZINE-2-ONE THAT ARE APPLICABLE AS HIV REVERSTRANSCRIPTASE INHIBITORS, INTERMEDIATE PRODUCTS AND METHODS FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
CN1145618C (en) 2004-04-14
EA004512B1 (en) 2004-04-29
NZ515355A (en) 2004-02-27
CN1349517A (en) 2002-05-15
AU766428B2 (en) 2003-10-16
BR0010213A (en) 2002-02-19
CZ20013951A3 (en) 2002-05-15
MXPA01011286A (en) 2003-07-14
AU4688600A (en) 2000-11-17
CA2371726A1 (en) 2000-11-09
SG114650A1 (en) 2005-09-28
EP1173426A1 (en) 2002-01-23
NO321361B1 (en) 2006-05-02
SK15912001A3 (en) 2002-06-04
TR200103286T2 (en) 2002-07-22
HUP0201609A3 (en) 2002-12-28
BG106079A (en) 2002-05-31
PL351127A1 (en) 2003-03-24
JP2002543193A (en) 2002-12-17
EA200101176A1 (en) 2002-04-25
HUP0201609A2 (en) 2002-08-28
NO20015378L (en) 2002-01-03
KR20010114250A (en) 2001-12-31
IL146280A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
NO20015272L (en) Glucocorticoid receptor modulators
NO20015314L (en) steroid Derivatives
NO20051042L (en) Pyrimidylsulfonamide derivatives as chemokine receptor modulators
DE60327767D1 (en) TRICYCLIC STEROID HORMONIC RECEPTOR MODULATORS
DK1526134T3 (en) Triazolyltropane derivatives as CCR5 modulators
NO20013671L (en) Substituted bisyclic derivatives useful as anticancer agents
AU2003230581A1 (en) Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
NO20013997L (en) Receptor
DK1027342T3 (en) Cyclopentene derivatives as motilin receptor antagonists
NO20013860D0 (en) 16-hydroxyostratrienes as selective estrogens
HK1070362A1 (en) Non-steroidal progesterone receptor modulators
DK1467998T3 (en) Tetracyclic hetero compounds as estrogen receptor modulators
NO20015378D0 (en) Cyclocarbamate derivatives as progesterone receptor modulators
NO20021295L (en) Nikotinsyreacetylcholin receptor
NO20032415L (en) Compounds active on glucocorticoid receptor II
HK1043789A1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
HK1043989A1 (en) Cyclocarbamate derivatives as progesterone receptor modulators
ZA200107633B (en) Cyclothiocarbamate derivatives as progesterone receptor modulators.
ZA200107630B (en) Cyclocarbamate derivatives as progesterone receptor modulators.
DK1159267T3 (en) N-substituted indolines as estrogenic agents
NO20021249D0 (en) Tienoisoxazolophenoxy substituted ethyl and propyl derivatives as D4 antagonists

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application